Widespread decrease of nicotinic acetylcholine receptors in Parkinson's disease
β Scribed by Masahiro Fujita; Masanori Ichise; Sami S. Zoghbi; Jeih-San Liow; Subroto Ghose; Douglass C. Vines; Janet Sangare; Jian-Qiang Lu; Vanessa L. Cropley; Hidehiro Iida; Kyeong Min Kim; Robert M. Cohen; William Bara-Jimenez; Bernard Ravina; Robert B. Innis
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 136 KB
- Volume
- 59
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Dopamine D1-like and D2-like receptors on peripheral blood lymphocytes (PBL) were assayed in 50 de novo patients with idiopathic Parkinson's disease (PD), in 36 neurologic control subjects (multiple-system atrophy, n β«Χ‘β¬ 16; essential tremor, n β«Χ‘β¬ 10; other neurodegenerative diseases, n β«Χ‘β¬ 10), an
Tomographic imaging of central nicotinic acetylcholine receptors (nAChRs) via single photon emission computed tomography (SPECT) has been hampered by the lack of a radioligand with suitable in vivo binding characteristics. Therefore, a novel analog of epibatidine, (6)-exo-2-(2-iodo-5-pyridyl)-7-azab